Valiant Co

Valiant Co Goodwill/Assets

The Goodwill to Total Assets Ratio of Valiant Co (002643.SZ) as of Oct 26, 2026 is 5.79 %. In the previous year, Goodwill to Total Assets Ratio was 6.37 % — a change of -9.14% (lower).

Goodwill/Assets

5.79 %

YoY

-9.14%

Last updated:

Goodwill to Total Assets Ratio of Valiant Co is 2025 5.79 % . Goodwill to Total Assets Ratio of Valiant Co was 2024 6.37 % . It decreases by -9.14% lower compared to the previous year.

The Valiant Co Goodwill/Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Goodwill/Assets
Date
Goodwill/Assets
Jan 1, 2018
14.27 CNY
Jan 1, 2019
11.74 CNY
Jan 1, 2020
9.74 CNY
Jan 1, 2021
8.05 CNY
Jan 1, 2022
7.48 CNY
Jan 1, 2023
6.95 CNY
Jan 1, 2024
6.37 CNY
Jan 1, 2025
5.79 CNY
The Valiant Co Goodwill/Assets history
YEARGoodwill/AssetsYoY
5.79 %-9.14%
6.37 %-8.39%
6.95 %-7.09%
7.48 %-7.13%
8.05 %-17.28%
9.74 %-17.10%
11.74 %-17.67%
14.27 %-6.60%
15.27 %-11.00%
17.16 %+17,613.61%
0.10 %-47.01%
0.18 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valiant Co Stock analysis

What does Valiant Co do? Valiant Co., Ltd. generates revenue through three core business segments. The Information Materials Industry segment produces and sells display materials and functional materials, targeting customers in the electronics and manufacturing sectors. The Environmental Protection Materials Industry segment develops and manufactures new zeolite environmental protection materials for tail gas purification, serving automotive and industrial clients requiring emission control solutions. The Large Health Industry segment focuses on pharmaceutical production, life sciences, and in vitro diagnostic services, catering to healthcare providers and medical facilities. The company's products include display materials, functional materials, new zeolite environmental protection materials, pharmaceuticals, and in vitro diagnostic services. These offerings are sold across the three industry segments, with the Environmental Protection Materials segment specifically addressing tail gas purification needs. The Large Health Industry segment's in vitro diagnostic services support healthcare operations through specialized medical solutions. Valiant Co., Ltd. serves diverse customer segments including electronics manufacturers, automotive industries, industrial emission control clients, and healthcare providers. The firm's revenue streams are derived from the sale of physical products like display materials and zeolite materials, as well as service-based offerings in diagnostics and pharmaceuticals. The company's business model relies on manufacturing and selling these products across its three operational segments. Valiant Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Valiant Co stock

Goodwill to Total Assets Ratio of Valiant Co is 5.79 % in 2025.

Goodwill to Total Assets Ratio of Valiant Co changed from 6.37 % to 5.79 %, representing a -9.14% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Goodwill to Total Assets Ratio Valiant Co since 2006 – with annual values, charts, and detailed analysis.

The Goodwill/Assets ratio shows what percentage of total assets consists of acquisition goodwill. High ratios may indicate impairment risk.

Goodwill to Total Assets Ratio's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Goodwill to Total Assets Ratio's Valiant Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Valiant Co

All Key Metrics — Valiant Co